Navigation Links
Rensselaer Professor Ryan Gilbert receives NSF CAREER award
Date:1/31/2012

Troy, N.Y. Ryan Gilbert, assistant professor in the Department of Biomedical Engineering at Rensselaer Polytechnic Institute, has won a prestigious Faculty Early Career Development Award (CAREER) from the National Science Foundation (NSF).

Gilbert will use the projected five-year, $500,000 award to develop new biomaterials for the treatment of spinal cord injuries. The CAREER Award is given to faculty members at the beginning of their academic careers and is one of NSF's most competitive awards, placing emphasis on high-quality research and novel education initiatives.

"We congratulate Dr. Gilbert for being selected to receive an NSF CAREER Award to support his leading-edge biomaterials research," said David Rosowsky, dean of the School of Engineering at Rensselaer. "The CAREER Award is one of the highest honors a young faculty member can receive, and Ryan is certainly deserving of this national recognition."

With his CAREER project, titled "Study of Astrocyte Migration and Reactivity Using Novel Biomaterial Platforms," Gilbert seeks to innovate a solution to the known problem of astrocyte reactivity. Individuals who suffer spinal cord injuries often lose body function below the injury site, which can lead to lifelong paralysis. Currently, there are no federally approved biological or drug-based treatments to restore this lost functionality, Gilbert said.

Gilbert's goal is to develop new biomaterials to reduce or eliminate the reactivity of astrocytes, glial cells found in the scar tissues of the spinal cord that are known to inhibit nerve regeneration. Additionally, Gilbert and his research team will develop polymer spheres that can travel through glial cells and scar tissue in order to deliver therapies to coax axons into the injury site. By delivering these therapies directly to the injury site and weakening the inhibitory nature of astrocytes, these new materials could aid the regeneration of nerve axons, he said. This research holds the promise of informing a new framework for developing novel strategies and treatments for spinal cord injury.

This research will be conducted in the world-class Center for Biotechnology and Interdisciplinary Studies (CBIS) at Rensselaer.

Along with educating undergraduates and graduate students in the areas of spinal cord injury research, advanced microscopy, and biomaterial fabrication, Gilbert's research program supports educational outreach initiatives to engage elementary, junior high school, and high school students about these important topics.

Gilbert joined the Rensselaer faculty in 2010, after serving as an assistant professor of biomedical engineering at Michigan Technological University (MTU). In 2008, he was inducted into MTU's Academy of Teaching Excellence. At Rensselaer, Gilbert currently advises four graduate students and five undergraduate students.

Gilbert received his bachelor's degree in chemical engineering from the University of Michigan, Ann Arbor, and his doctoral degree in biomedical engineering from Case Western Reserve University.


'/>"/>
Contact: Michael Mullaney
mullam@rpi.edu
518-276-6161
Rensselaer Polytechnic Institute
Source:Eurekalert  

Related biology news :

1. Trustee makes donation to start new solar energy research center at Rensselaer
2. Rensselaer receives more than $2 million from New York State to fund stem cell research
3. Rensselaer leads effort to replace 1 of the most widely used drugs in American hospitals
4. Rensselaer researchers to send bacteria into orbit aboard space shuttle Atlantis
5. Rensselaer Polytechnic Institute wins $2.45 million grant to support stem cell research
6. Rensselaer Polytechnic Institute professor Patrick Underhill receives NSF CAREER award
7. Rensselaer Polytechnic Institute professor Peter M. Tessier named Pew Scholar
8. Left or right? Early clues to soccer penalty kicks revealed at Rensselaer Polytechnic Institute
9. Rensselaer professor uncovers mysterious workings of cholera bacteria
10. Purifying proteins: Rensselaer researchers use NMR to improve drug development
11. Rensselaer professors Dordick and Interrante named ACS Fellows
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Rensselaer Professor Ryan Gilbert receives NSF CAREER award
(Date:2/8/2017)... Report Highlights ... The global synthetic-biology market reached nearly $3.9 ... growing at a compound annual growth rate (CAGR) of 24.0% ... global markets for synthetic biology. - Analyses of global market ... of compound annual growth rates (CAGRs) through 2021. - Coverage ...
(Date:2/7/2017)... , Feb. 7, 2017 Zimmer Biomet ... in musculoskeletal healthcare, will present at the LEERINK Partners ... York Palace Hotel on Wednesday, February 15, 2017 at ... webcast of the presentation can be accessed at ... following the conference via Zimmer Biomet,s Investor Relations website ...
(Date:2/3/2017)... , Feb. 3, 2017 A new independent ... Strategy Partners, LLP (IdSP) . Designed to fill a ... complex identity market, founding partners Mark Crego ... combined years just in identity expertise that span federal ... non-profit leadership. The Crego-Kephart combined expertise has a common ...
Breaking Biology News(10 mins):
(Date:2/23/2017)... , Feb. 23, 2017 /PRNewswire/ - The Fight Against ... Cancer Research (OICR) are pleased to report that Fusion ... financing, with Johnson & Johnson Innovation – JJDC, Inc. ... venture groups HealthCap, TPG Biotechnology Partners, and Genesys Capital, ... ...
(Date:2/23/2017)... 23, 2017  Imanis Life Sciences announced today ... oncolytic vaccinia viruses for virotherapy research. These viruses ... Genelux,s proprietary, vaccinia virus-based technology platform for research ... into a partnership with Genelux to offer researchers, ... for use in research," said Dr. Kah ...
(Date:2/23/2017)... ... February 23, 2017 , ... Today, researchers ... CRP, adiponectin, uric acid, and/or other biomarkers or SNPs of interest) using one, ... Salimetrics’ SalivaLab , the relationship between insulin and other relevant biomarkers can be ...
(Date:2/23/2017)... FRANCISCO , Feb. 23, 2017   ViaCyte, ... Type 1, a not-for-profit advocacy and education group for ... grant from Beyond Type 1 to support ViaCyte,s efforts ... other insulin-requiring diabetes.  For more than ... cell replacement therapies with a focus on the treatment ...
Breaking Biology Technology: